
Despite enhanced glycolysis being a key process in cancer biology, the effects of lactylation are not well known. A new study published in Nature Metabolism shed light on the lactylome profile of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), identifying a type of post-translational modification — non-histone lysine lactylation (Kla) — as an important player in HCC progression.
Like
Save
Share